J&J cutting back on stents, expects $500M charge

June 15, 2011 6:50:01 AM PDT
Johnson & Johnson will cut back on manufacturing and development of heart stents, and will take a charge of $500 million to $600 million as it restructures its Cordis heart device business.

Load Comments